CONGESTIVE HEART FAILURE GUIDELINES FROM METRICOR FOR COMMUNITY HOSPITAL CUT TREATMENT COSTS BY 25%: DRUG THERAPY INCREASES AS PERCENTAGE OF COST
Executive Summary
Congestive heart failure treatment guidelines developed for a community hospital in consultation with Metricor indicate that careful formulary selection can contribute to a 25% reduction in overall treatment costs per in-patient, according to a recent report by The Wilkerson Group. Metricor is a clinical practice guidelines development firm, created by a spin-off of three service firms from Louisville, Ky.-based Humana in 1992.